Pathogenesis of Cognitive Decline Following Therapeutic Irradiation for Head and Neck Tumors
نویسندگان
چکیده
منابع مشابه
Head and Neck Tumors: Management of Primary Undifferentiated Pleomorphic Sarcoma
Introduction: Sarcomas account for 1% of all tumors originated in the head and neck regions in adults. They constitute a heterogeneous group of tumors of mesenchymal origin with multiple histological variants. The undifferentiated pleomorphic sarcoma (UPS) subtype is the most frequent variant with an incidence range of 2.7-38%. Materials and Methods: This retrospective...
متن کاملHead and Neck Pathology: New Developments in the Diagnosis and Pathogenesis of Head and Neck Tumors
1Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA 2Department of Pathology, University of Virginia Charlottesville, VA 22908, USA 3Division of Oral Pathology, University of Minnesota, Minneapolis, MN 55455, USA 4Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, The Methodist Hospital Physicians Organ...
متن کاملDesmoid tumors of the head and neck: a therapeutic challenge.
Desmoid tumor, or aggressive fibromatosis, is a rare, histologically benign, fibroblastic lesion that infrequently presents in the head and neck. Desmoid tumors often grow locally, invasively, and may, in rare instances, be fatal secondary to invasion into critical structures, such as airway or major vessels. The most common treatment is surgery, but desmoid tumors are characteristically associ...
متن کاملHead and neck solitary fibrous tumors: diagnostic and therapeutic challenges.
OBJECTIVES/HYPOTHESIS Head and neck solitary fibrous tumors (SFTs) are quite rare, with <200 cases reported in the literature. The purpose of this study was to analyze the diagnostic and therapeutic challenges of this rare disease while reporting the largest head and neck case series. STUDY DESIGN Retrospective review. METHODS Between 1991 and 2011, 13 cases of head and neck SFTs from the p...
متن کاملHead and neck tumors
In 2003, it is estimated that head and neck cancers will comprise 2%-3% of all cancers in the United States and account for 1%-2% of all cancer deaths. This total includes 19,400 cases of oral cavity cancers, 9,500 cases of laryngeal cancer, and 8,300 cases of pharyngeal cancer. Most patients with head and neck cancer have metastatic disease at the time of diagnosis (regional nodal involvement ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Oncologica
سال: 2002
ISSN: 0284-186X,1651-226X
DOI: 10.1080/028418602760169389